LGND Stock Tickeron detected bullish Stock Pattern: Triangle Symmetrical Top LGND on January 21, 2025, netting in a 12.39% gain over 1 month

GET DAILY SIGNALS

Get AI intraday signals

LGND - Ligand Pharmaceuticals

Ticker: LGND

Company: Ligand Pharmaceuticals

Gain: +12.39%

Confirmed: 01/21/25

Succeeded: 02/19/25

Total length: 36 days

LGND in upward trend: price may jump up because it broke its lower Bollinger Band on February 11, 2025

LGND may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 40 cases where LGND's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 14, 2025. You may want to consider a long position or call options on LGND as a result. In of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for LGND just turned positive on February 18, 2025. Looking at past instances where LGND's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .

LGND moved above its 50-day moving average on February 14, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LGND crossed bullishly above the 50-day moving average on January 29, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where LGND advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LGND declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for LGND entered a downward trend on January 23, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. LGND’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.711) is normal, around the industry mean (12.644). P/E Ratio (48.462) is within average values for comparable stocks, (84.748). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.591). LGND has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (14.535) is also within normal values, averaging (254.739).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.